Mortgage Capital Markets Insights & News by MCT

Leverage secondary market strategies, daily market commentary, and mortgage indices from the MCT Learning Center to elevate your performance and your career.

Filter By Solution


Filter by Type


Filter by Topic


Filter by Learning Level


Click to read the most recent MSR Market Update! - Here we go again! Mortgage rates and all other rate indices continue their roller-coaster ride (…)
Click to read the most recent MSR Market Update! - Finally, inflation data signals that the Fed’s anticipated rate reduction action is coming very soon, (…)
Click to read the most recent MSR Market Update! - The Fed’s recent announcement indicated no changes to the current Fed Funds rate, hence opening (…)
Click to read the most recent MSR Market Update! - Mortgage rates and other rate indices have managed to remain at relatively about the same (…)
Click to read the most recent MSR Market Update! - Mortgage rates and some rate indices have experienced a slight retreat from their end of (…)
Click to watch this video and see what David Burruss has to advise on bulk MSR sales. - In this video, Mr. Burruss discusses industry (…)
Click to read the most recent MSR Market Update! - Mortgage rates and some rate indices have experienced a healthy recovery from their lows recorded (…)
The economy continues to heal from the pandemic and MSR pricing has seen improvement as a result. Many servicers are still sitting on large portfolios (…)

Join the MCT Newsletter

Keep up with industry-changing innovations, MBS market movements, and growth opportunities that impact your mortgage capital markets operation.

Read Latest MCT Market Commentary

Have a specific question?

Track the Market with MCT’s Mortgage Lock Volume Index

As the leader in mortgage capital markets technology, MCT supports more lenders than any other single provider. This privileged position supports analysis of a meaningful population of data into macro insights. MCT’s mortgage lock volume indices are based on actual locked loans, not applications, and are therefore a more accurate indication compared to alternatives.